Atria Investments Inc Lowers Holdings in GRAIL, Inc. $GRAL

Atria Investments Inc lowered its holdings in GRAIL, Inc. (NASDAQ:GRAL) by 15.7% during the second quarter, Holdings Channel.com reports. The firm owned 6,711 shares of the company’s stock after selling 1,253 shares during the period. Atria Investments Inc’s holdings in GRAIL were worth $345,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its position in shares of GRAIL by 21.4% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 34,195 shares of the company’s stock worth $1,758,000 after purchasing an additional 6,032 shares during the last quarter. Scientech Research LLC purchased a new position in GRAIL during the first quarter worth about $644,000. Wesbanco Bank Inc. increased its position in shares of GRAIL by 39.1% during the second quarter. Wesbanco Bank Inc. now owns 44,500 shares of the company’s stock valued at $2,288,000 after acquiring an additional 12,500 shares during the last quarter. Dakota Wealth Management acquired a new stake in shares of GRAIL during the second quarter valued at about $2,656,000. Finally, Raymond James Financial Inc. raised its stake in shares of GRAIL by 354.7% in the 1st quarter. Raymond James Financial Inc. now owns 121,169 shares of the company’s stock valued at $3,095,000 after acquiring an additional 94,518 shares during the period.

Insider Buying and Selling at GRAIL

In other news, CEO Robert P. Ragusa sold 7,239 shares of GRAIL stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total value of $498,622.32. Following the completion of the transaction, the chief executive officer owned 727,388 shares in the company, valued at approximately $50,102,485.44. This trade represents a 0.99% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, President Joshua J. Ofman sold 81,385 shares of the company’s stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $62.50, for a total transaction of $5,086,562.50. Following the sale, the president owned 396,797 shares in the company, valued at $24,799,812.50. The trade was a 17.02% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 117,497 shares of company stock valued at $7,515,436 over the last three months.

GRAIL Stock Down 2.0%

GRAIL stock opened at $83.39 on Wednesday. GRAIL, Inc. has a 52-week low of $13.58 and a 52-week high of $103.00. The firm has a market cap of $3.01 billion, a PE ratio of -6.36 and a beta of 4.31. The company’s 50 day moving average is $63.98 and its two-hundred day moving average is $47.40.

GRAIL (NASDAQ:GRAL) last posted its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) earnings per share for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The company had revenue of $35.54 million for the quarter, compared to analysts’ expectations of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. On average, equities research analysts anticipate that GRAIL, Inc. will post -15.15 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on GRAL shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of GRAIL in a research report on Wednesday, October 8th. UBS Group set a $75.00 price target on GRAIL in a research report on Friday, October 3rd. Finally, Canaccord Genuity Group boosted their price objective on GRAIL from $75.00 to $85.00 and gave the company a “buy” rating in a report on Wednesday, October 22nd. One analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $60.00.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.